| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.02 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.02 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.02 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.73 | 0.02 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |